Moderna: Q3 Earnings Snapshot
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Thursday reported a loss of $3.63 billion in its third quarter.
The Cambridge, Massachusetts-based company said it had a loss of $9.53 per share. Losses, adjusted for non-recurring costs, were $1.39 per share.
The results surpassed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $2.01 per share.
The biotechnology company posted revenue of $1.83 billion in the period, which also topped Street forecasts. Ten analysts surveyed by Zacks expected $1.33 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNA at https://www.zacks.com/ap/MRNA